These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24895021)

  • 1. Decline of defibrillation testing in the clinical practice: an 8-year nation-wide assessment.
    Brignole M; Occhetta E; Grazia Bongiorni M; Proclemer A; Favale S; Gasparini M; Accardi F; Valsecchi S
    Europace; 2014 Aug; 16(8):1103-4. PubMed ID: 24895021
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ; Exner DV; Wathen MS; Sherfesee L; Scinicariello AP; Gillberg JM
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):280-9. PubMed ID: 20958831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
    Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
    Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856
    [No Abstract]   [Full Text] [Related]  

  • 6. Standards for device implantation and follow-up: personnel, equipment, and facilities: results of the European Heart Rhythm Association Survey.
    Todd D; Bongiorni MG; Hernandez-Madrid A; Dagres N; Sciaraffia E; Blomström-Lundqvist C;
    Europace; 2014 Aug; 16(8):1236-9. PubMed ID: 25074974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of defibrillation threshold testing in the contemporary defibrillator patient population.
    Vischer AS; Sticherling C; Kühne MS; Osswald S; Schaer BA
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):437-41. PubMed ID: 23210803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH; Van Gelder IC
    Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457
    [No Abstract]   [Full Text] [Related]  

  • 9. Troubleshooting implanted cardioverter defibrillator sensing problems I.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1237-61. PubMed ID: 25516582
    [No Abstract]   [Full Text] [Related]  

  • 10. Inappropriate implantable cardioverter-defibrillator shocks in a public swimming pool.
    Alzand BS; Leemput N; Willems R
    Europace; 2014 Aug; 16(8):1124. PubMed ID: 24192323
    [No Abstract]   [Full Text] [Related]  

  • 11. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.
    Russo AM; Chung MK
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423
    [No Abstract]   [Full Text] [Related]  

  • 12. Troubleshooting implantable cardioverter-defibrillator sensing problems II.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):212-20. PubMed ID: 25691555
    [No Abstract]   [Full Text] [Related]  

  • 13. Is defibrillation testing necessary?
    Russo AM; Chung MK
    Cardiol Clin; 2014 May; 32(2):211-24. PubMed ID: 24793798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged sustained ventricular fibrillation in a patient with dextrocardia and a left ventricular assist device.
    Bolzan B; Morani G; Tomei R; Tomasi L; Borio G; Ribichini FL
    J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):721-724. PubMed ID: 31389822
    [No Abstract]   [Full Text] [Related]  

  • 15. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated vulnerability testing identifies patients with inadequate defibrillation safety margin.
    Birgersdotter-Green U; Ruetz LL; Anand K; Monir G; Abeyratne AI; Bailey JR; Shorofsky SR; Hsia HH; Friedman PA
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1073-80. PubMed ID: 23051838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible late diagnosis of the Brugada syndrome in a patient presenting with a primary cardiac arrest.
    Moore PT; Kaye GC
    Europace; 2015 Dec; 17(12):1839. PubMed ID: 25911350
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator.
    Adduci C; Spadoni L; Palano F; Francia P
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1373-1374. PubMed ID: 31165543
    [No Abstract]   [Full Text] [Related]  

  • 19. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
    Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
    Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Omitting Defibrillation Efficacy Testing With Subcutaneous Defibrillators: A Propensity-Matched Case-Control Study.
    Bianchi V; Bisignani G; Migliore F; Biffi M; Nigro G; Viani S; Caravati F; Checchi L; Francia P; De Filippo P; Pecora D; Lavalle C; Scalone A; Rossi P; Palmisano P; Licciardello G; Ospizio R; Lovecchio M; Valsecchi S; D'Onofrio A;
    Circ Arrhythm Electrophysiol; 2021 Dec; 14(12):e010381. PubMed ID: 34852635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.